Recent polling indicates significant Iranian public resistance to Western demands, impacting market predictions related to the Iranian regime. The chances of an Iranian regime change by June 30 have slightly decreased to 7.5% from 8% just a day prior. Similarly, the likelihood of Iran consenting to halt its uranium enrichment has plummeted to 4% from a previous 56% just last week.
A look into the polling results reveals robust backing for the Iranian Revolutionary Guard Corps, showing that the populace largely opposes any concessions. Specifically, 79% of those surveyed rejected the idea of stopping uranium enrichment. This public sentiment is reflected in trading metrics; the regime change market is currently seeing a daily volume of $33,440, with notable recent volatility, including a 1-point price jump. On the uranium enrichment front, trading activity in that market averaged $4,865 daily, exhibiting a significant two-point shift amidst a general decline in prices as the deadline approaches.
#Why Should Investors Pay Attention?
Understanding these market dynamics is crucial. The regime fall market exhibits a price movement resistance, needing close to $13,929 to shift by five points, indicating a moderated market scenario. Conversely, the uranium market, with only $2,731 at the same threshold, proves to be less stable, more likely influenced by substantial individual trades.
#What Should Investors Watch For Now?
As an investor, one should keep an eye on the potential return of a YES share on the uranium agreement, which is currently priced at four cents, potentially netting a dollar if Iran agrees before April 30. This scenario represents a risk-reward ratio of 25 times. However, this gamble hinges on an expected, yet currently unlikely, shift in Iran's policy within the next six days, contrary to the polling evidence.
Key indicators to monitor include announcements from Iranian officials or changes in U.S. foreign policy. Given the strong backing for the IRGC and the reported public resistance to enriching concessions, it appears unlikely that any significant breakthroughs will occur before the upcoming deadline.